PFASs possess thyroid-disrupting effects through various mechanisms, such as binding to transthyretin, activating the NA+/K+-dependent transport of I−, binding to the sites of deiodinases, and inducing transcriptional changes in thyroid-regulating genes (28–30). The gene discussed is TTR; the disease is thyroid gland disorder.